Asian Undervalued Small Caps With Insider Buying To Watch
In recent weeks, Asian markets have been navigating a complex landscape marked by global trade tensions and inflationary pressures, which have contributed to fluctuating investor sentiment. Amid these challenges, small-cap stocks in Asia present intriguing opportunities for investors seeking growth potential at attractive valuations. Identifying promising small caps involves looking for companies with strong fundamentals and insider buying activity, which can signal confidence in the company's future prospects even amidst broader economic uncertainties.
Name
PE
PS
Discount to Fair Value
Value Rating
Security Bank
4.7x
1.1x
36.89%
★★★★★★
Atturra
27.5x
1.1x
39.97%
★★★★★☆
Dicker Data
19.3x
0.7x
-41.10%
★★★★☆☆
Puregold Price Club
9.0x
0.4x
15.84%
★★★★☆☆
Hansen Technologies
285.2x
2.8x
27.68%
★★★★☆☆
Sing Investments & Finance
7.4x
3.8x
35.03%
★★★★☆☆
Viva Energy Group
NA
0.1x
19.20%
★★★★☆☆
Fenix Resources
15.7x
0.8x
14.79%
★★★☆☆☆
Integral Diagnostics
151.6x
1.7x
41.91%
★★★☆☆☆
Manawa Energy
NA
2.7x
36.49%
★★★☆☆☆
Click here to see the full list of 58 stocks from our Undervalued Asian Small Caps With Insider Buying screener.
We're going to check out a few of the best picks from our screener tool.
Simply Wall St Value Rating: ★★★★☆☆
Overview: Dicker Data is a wholesale distributor specializing in computer peripherals, with a market capitalization of A$1.94 billion.
Operations: The company's revenue primarily stems from wholesale computer peripherals, with a gross profit margin reaching 14.55% as of March 2025. Cost of goods sold (COGS) significantly influences the financials, while operating expenses and non-operating expenses also play vital roles in determining net income.
PE: 19.3x
Dicker Data, a prominent player in the tech distribution sector, recently announced a strategic partnership with CrowdStrike to enhance its cybersecurity offerings across Australia and New Zealand. Despite high debt levels due to reliance on external borrowing, Dicker Data's earnings are projected to grow by 9.38% annually. Insider confidence is evident as they increased their stake between January and March 2025. With A$2.28 billion in revenue for 2024, the company continues to expand its market footprint amidst rising demand for advanced cybersecurity solutions.
Dive into the specifics of Dicker Data here with our thorough valuation report.
Assess Dicker Data's past performance with our detailed historical performance reports.
Simply Wall St Value Rating: ★★★☆☆☆
Overview: Precinct Properties NZ & Precinct Properties Investments is a New Zealand-based real estate company focused on investment properties, flexible space, hotel and hospitality sectors, with a market capitalization of approximately NZ$1.56 billion.
Operations: Precinct Properties generates its revenue primarily from Investment Properties, contributing NZ$215.60 million, followed by Flexible Space and Hotel and Hospitality segments. The company's gross profit margin has shown a decreasing trend over recent periods, dropping to 62.61% as of December 2024. Operating expenses have remained relatively stable in the range of NZ$20-22 million.
PE: -63.0x
Precinct Properties, a smaller player in the Asian market, recently reported half-year sales of NZ$134.4 million, up from NZ$121 million the previous year. However, net income dipped to NZ$9.2 million from NZ$15.3 million. Despite this decline, insider confidence is evident with recent share purchases by insiders indicating potential growth prospects. The company faces challenges with interest payments not fully covered by earnings and relies entirely on external borrowing for funding. Earnings are projected to grow significantly at 64.98% annually, suggesting future value potential amidst current undervaluation concerns.
Click to explore a detailed breakdown of our findings in Precinct Properties NZ & Precinct Properties Investments' valuation report.
Explore historical data to track Precinct Properties NZ & Precinct Properties Investments' performance over time in our Past section.
Simply Wall St Value Rating: ★★★★☆☆
Overview: Shanghai Haohai Biological Technology is engaged in the production and sale of biologics, specifically focusing on medical hyaluronic acid, with a market capitalization of CN¥15.30 billion.
Operations: The company's revenue primarily comes from the production and sale of biologics, particularly medical hyaluronic acid. Over time, the gross profit margin has shown a declining trend, reaching 69.10% by September 2024. Operating expenses have been substantial, with sales and marketing being a significant component. The net income margin was recorded at 15.66% in September 2024.
PE: 14.1x
Shanghai Haohai Biological Technology, a smaller company in the Asian market, shows potential for growth with earnings projected to increase by 12% annually. Despite relying on higher-risk external borrowing for funding, insider confidence is evident as CFO Minjie Tang purchased 10,000 shares recently. The company reported modest sales growth to CNY 2.7 billion and net income of CNY 420 million for 2024. Although dividends decreased to RMB 0.6 per share, the firm completed a buyback of nearly half a million shares valued at CNY 30.58 million last year.
Unlock comprehensive insights into our analysis of Shanghai Haohai Biological Technology stock in this valuation report.
Examine Shanghai Haohai Biological Technology's past performance report to understand how it has performed in the past.
Get an in-depth perspective on all 58 Undervalued Asian Small Caps With Insider Buying by using our screener here.
Hold shares in these firms? Setup your portfolio in Simply Wall St to seamlessly track your investments and receive personalized updates on your portfolio's performance.
Simply Wall St is your key to unlocking global market trends, a free user-friendly app for forward-thinking investors.
Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.
Find companies with promising cash flow potential yet trading below their fair value.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include ASX:DDR NZSE:PCT and SEHK:6826.
Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@simplywallst.com
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Insider
18 minutes ago
- Business Insider
Upcoming Stock Splits This Week (June 9 to June 13)
These are the upcoming stock splits for the week of June 9 to June 13, based on TipRanks' Stock Splits Calendar. A stock split is a corporate maneuver that increases the number of shares outstanding by issuing more shares to existing holders, all while keeping the company's total market value unchanged. This lowers the price per share, often making the stock more affordable and potentially more appealing to retail investors. Confident Investing Starts Here: In contrast, a reverse stock split reduces the number of shares by consolidating them, which raises the price per share without affecting the company's valuation. Companies typically turn to this strategy to meet stock exchange requirements – like Nasdaq's minimum price threshold – and avoid delisting. Whether intended to boost investor interest or maintain compliance with exchange rules, these adjustments often serve as key signals for traders tracking a company's strategic direction. Let's take a look at the upcoming stock splits for the week. Nektar Therapeutics (NKTR) – Nektar Therapeutics is a biopharmaceutical company developing novel drug candidates. Following stockholder approval on May 23, the company formalized a 1-for-15 reverse stock split. The split takes effect on June 8, with trading on a split‑adjusted basis beginning June 9. Fangdd Network Group (DUO) – China-based Fangdd is a technology-driven real estate platform. The company confirmed a 16-for-1 reverse share consolidation, effective June 9, aimed at boosting its share price and maintaining compliance with listing standards. Bone Biologics (BBLG) – Bone Biologics develops orthobiologic products for spinal fusion procedures. After gaining shareholder approval on May 30, the company filed for a 1-for-6 reverse stock split, which takes effect on June 10. The goal is to elevate its share price back into compliance with Nasdaq's minimum pricing rules and enhance its appeal to institutional investors. Cero Therapeutics Holdings (CERO) – Cero Therapeutics is a biotech firm developing engineered T-cell immunotherapies for cancer. Following shareholder approval in November and board action on December 25, it enacted a 1-for-100 reverse stock split effective on January 8, consolidating every 100 shares into one. The move aimed to boost the stock above $1.00 and secure compliance with Nasdaq's listing standards. Inuvo, Inc. (INUV) – Inuvo specializes in AI-powered marketing technologies and is gearing up for a 1-for-10 reverse stock split on June 10. The move is designed to lift its share price, restore Nasdaq compliance, and strengthen its financial foundation for future growth. O'Reilly Automotive (ORLY) – O'Reilly Automotive is a specialty retailer of automotive aftermarket parts and accessories. On March 13, the company declared a 15-for-1 forward stock split, with the distribution of additional shares set for June 9 and split-adjusted trading beginning June 10. SaverOne 2014 (SVRE) – Israel-based SaverOne develops driver safety systems that block mobile-device distractions in vehicles. The company executed a 1-for-3 reverse ADS split, effective June 11, adjusting its American Depositary Share ratio to strengthen its Nasdaq standing and enhance market appeal. China Natural Resources, Inc. (CHNR) – China Natural Resources is focused on mining exploration in Inner Mongolia and is working toward picking up Zimbabwe's Williams Minerals lithium mine for up to $1.75 billion. The company executed an 8-for-1 reverse stock split effective June 12 to meet Nasdaq's $1 minimum bid price requirement, converting every eight shares into one to boost its per-share value and comply with listing rules
Boston Globe
2 hours ago
- Boston Globe
The Trump administration canceled an $87 million award for this MIT startup. But life goes on.
Advertisement On May 20, Suffolk Technologies, a venture capital arm of Boston-based Suffolk Construction, announced it had invested an unspecified amount of money in Sublime and pre-purchased some of the cement that will be made in Holyoke. Two days later, Sublime announced an agreement with Microsoft in which the software giant will buy more than 620,000 metric tons of Sublime cement over up to nine years. Last fall, two of the world's largest cement suppliers, Holcim and CRH, together invested $75 million in the company. The company has also raised $45 million in venture capital funding, including from Lowercarbon Capital and Engine Ventures. And on Thursday, Sublime disclosed a roster of nine construction companies, including Suffolk, that have agreed to act as sales partners to pitch Advertisement The Holyoke factory is expected to be completed in 2027 and provide jobs for at least 70 people after it opens. The plant will still get some subsidies, including $47 million in federal tax credits that remain in place, $1.05 million in state tax credits, and $351,000 in local property tax breaks. Site work has begun in Holyoke, but not construction of the actual building. Joe Hicken, senior vice president of business development at Sublime, declined to say what kind of impact, if any, the Department of Energy's action will have on the project's timing. He noted that Sublime's mission dovetails with the Trump administration's goal of boosting American manufacturing. 'If anything, that termination letter is one data point,' Hicken said. 'We have many other data points associated with commercial movement [and] for every plan that we talk about publicly, we have 10 backup plans waiting for their day to shine.' Builders such as those at Suffolk and Consigli Construction in Milford have come to appreciate the technology developed by Sublime cofounders Leah Ellis and Yet-Ming Chiang. The process they developed replaces traditional kilns with electrolysers that make cement from calcium sources, avoiding the intense release of carbon dioxide from the super-heating of limestone used to make most cement. So far, Sublime's production has been limited to small test batches, including a foundation section included in the new building WS Development finished for Amazon in the Seaport. Consigli vice president Todd McCabe said his company signed up to sell Sublime cement because its executives are always looking for ways to build more sustainably and efficiently, and Sublime's clean cement will help with that. Advertisement At Suffolk, executives decided to buy equity in Sublime. Suffolk followed the startup soon after its 2020 inception. As Sublime moved closer to commercialization, Suffolk chief technology officer Jit Kee Chin decided it was the right time to invest. 'They're getting to the point where it's about to go to market,' Chin said. 'Really, it's no longer a science experiment. ... This is the right time for us to go in and really support them.' Chin said many of Suffolk's clients are keenly interested in Sublime's goal of creating a cost-effective, low-carbon cement that's just as effective as traditional cement, known as portland cement. The news about Sublime losing the federal award came as a disappointment to Ben Downing, the chief strategist at the Engine, a nonprofit startup accelerator affiliated with MIT and with VC firm Engine Ventures. Although it's a significant amount of money, Downing has confidence that Sublime will be able to finish the Holyoke factory. 'We know there's a lot of chaos in Washington but we believe in the science and we believe in the team,' Downing said. 'It's bad news, but if any team is going to be able to respond to it and grow and scale it, they're going to find a way [and] I know Holyoke and Massachusetts will be better for it.' Jon Chesto can be reached at
Yahoo
4 hours ago
- Yahoo
London must ‘market its successes better' to avoid another Wise
Britain must emulate the success of Nasdaq and get better at trumpeting its business success stories if it wants to attract more companies to list in London, one of the UK's top fintech venture capital investors has said. Speaking to City AM the day that payments darling Wise revealed plans to ditch its primary listing for New York, Anthemis founder Amy Nauiokas said the London Stock Exchange (LSE) should try emulate the support promotion the US's tech-heavy bourse gives its new constituents. 'It's not brain surgery,' said Nauiokas, whose firm has been an early-stage backer of fintech success stories like Etoro, Zoopla and Tide. 'They [the LSE] need to promise UK entrepreneurs that there's a path here, and that they'll support them, build an ecosystem around them, and give the perks that the Nasdaq gives them.' London capital markets have been locked in a multi-year struggle to attract and retain some of its brightest companies. Since the start of 2024 alone, cherished listed firms like Darktrace, TUI and most DS Smith have all delisted or been taken private from the capital's stock market. And promising UK-headquartered scale-ups like Arm have opted to list in New York over London, with other darlings like Revolut and Klarna looking likely to follow suit. Departed firms have tended to cite London's stubbornly low valuations and lower liquidity relative to its US rivals, but Nauiokas argued that the lengths to which New York goes to promote and celebrate its new additions was just as important a factor. Commenting on the Nasdaq's custom of advertising its fresh listings in New York's Time Square, she said: 'Half the reason why people go there is so they get to see their their picture on 45th Street.' Her comments ring true with the rationale for ditching London given by Wise, which floated in the UK to great fanfare in 2021. Billionaire cofounder Kristo Kaarmannder said a US listing would help raise Wise's profile in the country as it joins the many London-based fintech giants looking to expand their services in the world's largest market. 'We believe the addition of a primary US listing would help us accelerate our mission and bring substantial strategic and capital market benefits to Wise and our owners,' he said in the firm's statement announcing its planned departure. Nauiokas, whose firm invests in start-ups in both the US and UK with offices in both New York and London, said she understood the Wise board's decision, adding that were she a secondary capital and pre-IPO dealmaker, she 'would probably say the best option right now was either a dual listing or a US-based IPO'. But despite the downbeat rhetoric surrounding the London Stock Exchange, she added that the ongoing political turmoil in America was something on which London – and Europe as a whole – should be poised to capitalise. 'It strikes me that all the opportunity is here [in London],' she said. 'This is a moment. A moment for investors to find great entrepreneurs and make money, but also a moment for regulatory navel gazing – government navel gazing – private partnership navel gazing – to say we could do something here. Let's do something.' Family offices and institutional money are increasingly looking to reduce the weighting of US assets in their portfolio in response to the capricious and unpredictable policy directives from the White House, Nauiokas said. Many ultra-rich families have re-weighted their portfolios from an '80/20 North America to Europe to now 50/50'. 'I'm super excited about the UK specifically. But it needs to take this moment of market geopolitical dislocation,' she said, adding: 'The LSE can do a much better job of reshaping its proposition, and the government needs to get rid of stamp duty on shares.' Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
